Biomedical Engineering Reference
In-Depth Information
Mauro, M. J., Druker, B. J. andMaziarz, R. T. 2004. Divergent clinical outcome in two CML
patients who discontinued imatinib therapy after achieving a molecular remission. Leuk
Res 28 Suppl 1:S71-3.
Mazieres, J., You, L., He, B., Xu, Z., Lee, A. Y., Mikami, I., McCormick, F. and Jablons, D.M.
2005. Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the
t(1;19) translocation induces apoptosis. Oncogene 24:5396-400.
McCormack, E., Bruserud, O. and Gjertsen, B. T. 2008. Review: genetic models of acute
myeloid leukaemia. Oncogene 27:3765-79.
Merchant, A. A., Joseph, G. A., Jones, E., Lin, T., Smith, B. D., McDevitt, M., Karp, J. E.,
Peacock, C., Watkins, D. N. and Matsui, W. H. 2007. Hedgehog signaling in normal and
malignant hematopoiesis. Blood 110:991a.
Messmer, B. T., Messmer, D., Allen, S. L., Kolitz, J. E., Kudalkar, P., Cesar, D., Murphy, E. J.,
Koduru, P., Ferrarini, M., Zupo, S., Cutrona, G., Damle, R. N., Wasil, T., Rai, K. R.,
Hellerstein, M. K. and Chiorazzi, N. 2005. In vivo measurements document the dynamic
cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 115:755-64.
Michor,F.,Hughes,T.P.,Iwasa,Y.,Branford,S.,Shah,N.P.,Sawyers,C.L.andNowak,M.A.
2005. Dynamics of chronic myeloid leukaemia. Nature 435:1267-70.
Miller, J. S., McCullar, V., Punzel, M., Lemischka, I. R. and Moore, K. A. 1999. Single adult
human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells,
dendritic cells, and myeloid cells. Blood 93:96-106.
Miller, W. H., Jr., Schipper, H. M., Lee, J. S., Singer, J. andWaxman, S. 2002. Mechanisms of
action of arsenic trioxide. Cancer Res 62:3893-903.
Morrison, S. J., Wandycz, A. M., Hemmati, H. D., Wright, D. E. and Weissman, I. L. 1997.
Identification of a lineage of multipotent hematopoietic progenitors. Development
124:1929-39.
Muller-Tidow, C., Steffen, B., Cauvet, T., Tickenbrock, L., Ji, P., Diederichs, S., Sargin, B.,
Kohler, G., Stelljes, M., Puccetti, E., Ruthardt, M., deVos, S., Hiebert, S. W., Koeffler, H. P.,
Berdel, W. E. and Serve, H. 2004. Translocation products in acute myeloid leukemia activate
the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol 24:2890-904.
Nakagawa, R., Soh, J. W. and Michie, A. M. 2006. Subversion of protein kinase C alpha
signaling in hematopoietic progenitor cells results in the generation of a B-cell chronic
lymphocytic leukemia-like population in vivo. Cancer Res 66:527-34.
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F.,
Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., Lechner, K., Nielsen, J. L.,
Rousselot, P., Reiffers, J., Saglio, G., Shepherd, J., Simonsson, B., Gratwohl, A.,
Goldman, J. M., Kantarjian, H., Taylor, K., Verhoef, G., Bolton, A. E., Capdeville, R.
and Druker, B. J. 2003. Imatinib compared with interferon and low-dose cytarabine for
newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348:994-1004.
O'Hare, T., Walters, D. K., Stoffregen, E. P., Jia, T., Manley, P. W., Mestan, J., Cowan-
Jacob, S. W., Lee, F. Y., Heinrich, M. C., Deininger, M. W. and Druker, B. J. 2005. In
vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant
imatinib-resistant Abl kinase domain mutants. Cancer Res 65:4500-5.
Oki, Y., Kantarjian, H. M., Gharibyan, V., Jones, D., O'Brien, S., Verstovsek, S., Cortes, J.,
Morris, G. M., Garcia-Manero, G. and Issa, J. P. 2007. Phase II study of low-dose
decitabine in combination with imatinib mesylate in patients with accelerated or myeloid
blastic phase of chronic myelogenous leukemia. Cancer 109:899-906.
Passegue, E., Jamieson, C. H., Ailles, L. E. and Weissman, I. L. 2003. Normal and leukemic
hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell character-
istics? Proc Natl Acad Sci USA 100 Suppl 1:11842-9.
Petropoulos, K., Arseni, N., Schessl, C., Stadler, C. R., Rawat, V. P., Deshpande, A. J.,
Heilmeier, B., Hiddemann, W., Quintanilla-Martinez, L., Bohlander, S. K., Feuring-
Buske, M. and Buske, C. 2008. A novel role for Lef-1, a central transcription mediator
of Wnt signaling, in leukemogenesis. J Exp Med 205:515-22.
